期刊文献+

Pharmacological management of portal hypertension:current status and future 被引量:4

原文传递
导出
摘要 Portal hypertension(PHT)is the trigger of the severe complications of cirrhosis,in eluding esophagogastric variceal bleeding(EVB),ascites,hepatic encephalopathy,cirrhotic cardiomyopathy,acute kidney injury and hepatorenal syndrome(AKI-HRS),which may cause death or increase the need for liver transplantation.11Of these,EVB remains one of the deadliest complications of PHT.As of now,the most widely accepted measure to assess portal pressure(PP)and PHT is the hepatic venous pressure gradient(HVPG)via transjugular-hepatic vein balloon catheterization?
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2020年第19期2362-2364,共3页 中华医学杂志(英文版)
基金 grants from the State Key Projects Specialized on Infectious Diseases(No.2017ZX10203202-004) the National Natural Science Foundation(No.81970525) the Beijing Natural Science Foundation Program and Scientific Research Key Program of Beijing Municipal Commission of Education(No.KZ201810025037) the Beijing Municipal Administration of Hospitals'Ascent Plan(No.DFL20151602).
  • 相关文献

参考文献4

二级参考文献85

  • 1李楠,敖国昆,王欣,朱建华,翟俊山,黄沁.磁共振血管成像在食管胃底静脉曲张形态学评估中的临床应用[J].中国全科医学,2009,12(8):681-683. 被引量:7
  • 2Natalie Funakoshi,Frédérique Ségalas-Largey,Yohan Duny,Frédéric Oberti,Jean-Christophe Valats,Michael Bismuth,Jean-Pierre Daurès,Pierre Blanc.Benefit of combination β-blocker and endoscopic treatment to prevent variceal rebleeding: A meta-analysis[J].World Journal of Gastroenterology,2010,16(47):5982-5992. 被引量:24
  • 3Cheng Liu,Cun-Meng Jiang,Cheng-Hai Liu,Ping Liu,Yi-Yang Hu From the Institute of Liver Diseases and Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China.Effect of Fuzhenghuayu decoction on vascular endothelial growth factor secretion in hepatic stellate cells[J].Hepatobiliary & Pancreatic Diseases International,2002,1(2):207-210. 被引量:19
  • 4Lei Li,Wei Liu,Yu-Han Chen,Chun-Lei Fan,Pei-Ling Dong,Fei-Li Wei,Bing Li,De-Xi Chen,Hui-Guo Ding.Antiviral drug resistance increases hepatocellular carcinoma:A prospective decompensated cirrhosis cohort study[J].World Journal of Gastroenterology,2013,19(45):8373-8381. 被引量:20
  • 5奥曲肽全国协作组.两种剂量奥曲肽治疗食管、胃静脉曲张大出血多中心随机对照临床疗效观察[J].中华消化杂志,2005,25(1):37-40. 被引量:55
  • 6Muir AJ, Poordad F, Lalezari J, Everson G, Dore GJ, Herring R, Sheikh A, Kwo P, H6zode C, Pockros PJ, Tran A, Yozviak J, Reau N, Ramji A, Stuart K, Thompson AJ, Vierling J, Freilich B, Cooper J, Ghesquiere W, Yang R, McPhee F, Hughes EA, $wenson ES, Yin PD. Daclatasvir in combination with asunaprevir and beclabuvir for hepatitis C virus genotype 1 infection with compensated cirrhosis. JAMA 2015; 313: 1736-1744.
  • 7World Health Organization. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. 2015 Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet 2014; 383:1749-1761.
  • 8Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Bin Abdulhak A, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, Burney P, Carapetis J, Chen H, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson Ki, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahodwala N, De Leo D, Degenhardt L, Delossantos A, Denenberg J, Des Jarlais DC, Dharmaratne SD, Dorsey ER, Driscoll T, Duber H, Ebel B, Erwin PJ, Espindola P, Ezzati M, Feigin V, Flaxman AD, Forouzanfar Mt-I, Fowkes FG, Franklin R, Fransen M, Freeman MK, Gabriel SE, Gakidou E, Gaspari F, Gillum RF, Gonzalez- Medina D, Halasa YA, Hating D, Harrison JE, Havmoeller R, Hay RJ, Hoen B, Hotez PJ, Hoy D, Jacobsen KH, James SL, Jasrasaria R, Jayaraman S, Johns N, Karthikeyan G, Kassebaum N, Keren A, Khoo JP, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Lipnick M, Lipshultz SE, Ohno SL, Mabweijano J, MacIntyreMF, Mallinger L, March L, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGrath J, Mensah GA, Merriman TR, Michaud C, Miller M, Miller TR, Mock C, Mocumbi AO, Mokdad AA, Moran A, Mulholland K, Nair MN, Naldi L, Narayan KM, Nasseri K, Norman P, O'Donnell M, Omer SB, Ortblad K, Osborne R, Ozgediz D, Pahari B, Pandian JD, Rivero AP, Padilla RP, Perez-Ruiz F, Perico N, Phillips D, Pierce K, Pope CA, Porrini E, Pourmalek F, Raju M, Ranganathan D, Rehm JT, Rein DB, Remuzzi G, Rivara FP, Roberts T, De Le6n FR, Rosenfeld LC, Rushton L, Sacco RL, Salomon JA, Sampson U, Sanman E, Schwebel DC, Segui-Gomez M, Shepard DS, Singh D, Singleton J, Sliwa K, Smith E, Steer A, Taylor JA, Thomas B, Tleyjeh IM, Towbin JA, Truelsen T, Undurraga EA, Venketasubramanian N, Vijayakumar L, Vos T, Wagner GR, Wang M, Wang W, Watt K, Weinstock MA, Weintraub R, Wilkinson JD, Woolf AD, Wulf S, Yeh PH, Yip P, Zabetian A, Zheng ZJ, Lopez AD, Murray CJ, A1Mazroa MA, Memish ZA. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380:2095-2128.
  • 9Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval F. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol 2013; 58:593-608.
  • 10Hoyert DL, Xu J. Deaths: preliminary data for 2011. Natl Vital Stat Rep 2012; 61:1-51.

共引文献342

同被引文献57

引证文献4

二级引证文献154

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部